AR059462A1 - Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos - Google Patents

Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos

Info

Publication number
AR059462A1
AR059462A1 ARP060101766A ARP060101766A AR059462A1 AR 059462 A1 AR059462 A1 AR 059462A1 AR P060101766 A ARP060101766 A AR P060101766A AR P060101766 A ARP060101766 A AR P060101766A AR 059462 A1 AR059462 A1 AR 059462A1
Authority
AR
Argentina
Prior art keywords
peptides derived
methods
pharmaceutical compositions
clear
caseina
Prior art date
Application number
ARP060101766A
Other languages
English (en)
Spanish (es)
Inventor
Jose Mario Iscovich
Nissim Silankovich
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of AR059462A1 publication Critical patent/AR059462A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ARP060101766A 2005-05-02 2006-05-15 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos AR059462A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67629205P 2005-05-02 2005-05-02
US68869705P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
AR059462A1 true AR059462A1 (es) 2008-04-09

Family

ID=37308387

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101766A AR059462A1 (es) 2005-05-02 2006-05-15 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos

Country Status (18)

Country Link
US (2) US7968513B2 (https=)
EP (1) EP1890720B1 (https=)
JP (1) JP5247429B2 (https=)
KR (2) KR20130122979A (https=)
CN (1) CN106421749A (https=)
AR (1) AR059462A1 (https=)
AU (1) AU2006242842B2 (https=)
BR (1) BRPI0611301A2 (https=)
CA (1) CA2607155C (https=)
CL (1) CL2011000039A1 (https=)
EA (1) EA016039B1 (https=)
ES (1) ES2400511T3 (https=)
IN (1) IN2014DN10391A (https=)
MX (1) MX2007013866A (https=)
NZ (1) NZ563936A (https=)
PL (1) PL1890720T3 (https=)
UY (1) UY29515A1 (https=)
WO (1) WO2006117784A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563936A (en) * 2005-05-02 2010-03-26 Mileutis Ltd Pharmaceutical compositions comprising casein derived peptides and methods of use thereof in decreasing dry period of lactation cycle in cows and increasing milk production
KR101033818B1 (ko) * 2008-06-30 2011-05-13 조아제약주식회사 돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도
US8133916B1 (en) 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution
US20110017323A1 (en) * 2009-07-22 2011-01-27 Ewa Herbst Method and apparatus for inline testing
WO2011132191A1 (en) 2010-04-21 2011-10-27 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
US9487557B2 (en) 2012-03-19 2016-11-08 Mileutis Ltd. Peptides for management of lactation
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins
AU2017358060B2 (en) * 2016-11-09 2023-05-04 Charles Sturt University Livestock supplement and use thereof
WO2018108975A1 (en) * 2016-12-13 2018-06-21 Dsm Ip Assets B.V. Pufa salt formulations (i)
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
WO2021168343A2 (en) * 2020-02-19 2021-08-26 Perfect Day, Inc. Hypoallergenic recombinant milk proteins and compositions comprising the same
JP2025537820A (ja) * 2022-11-17 2025-11-20 ミレウティス リミテッド． 乳房の障害および状態を調節するための組成物および方法
MX2025013554A (es) * 2023-05-16 2026-02-03 Mileutis Ltd Mejora de la calidad de la leche

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
CA2108678C (en) * 1991-04-19 2002-09-10 Eric C. Reynolds Production of phosphopeptides from casein
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
EP1206911A4 (en) 1999-08-24 2003-01-22 Meiji Seika Kaisha GROWTH-SUPPORTING COMPOSITIONS FOR MAMMALS AND METHOD FOR PROMOTING THE GROWTH OF MAMMALS USING THE SAME
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
KR20040008130A (ko) 2001-03-09 2004-01-28 메이지 세이카 가부시키가이샤 면역 증강제
EA200601575A1 (ru) 2004-03-01 2007-06-29 Пептера Фармасьютикалс Лтд. Казеиновые пептиды и их терапевтическое применение
NZ563936A (en) * 2005-05-02 2010-03-26 Mileutis Ltd Pharmaceutical compositions comprising casein derived peptides and methods of use thereof in decreasing dry period of lactation cycle in cows and increasing milk production

Also Published As

Publication number Publication date
EP1890720A2 (en) 2008-02-27
WO2006117784A3 (en) 2009-05-22
KR101340676B1 (ko) 2013-12-18
BRPI0611301A2 (pt) 2010-08-31
US20110212886A1 (en) 2011-09-01
US8338363B2 (en) 2012-12-25
EP1890720A4 (en) 2010-05-26
KR20130122979A (ko) 2013-11-11
CN106421749A (zh) 2017-02-22
EP1890720B1 (en) 2013-01-09
JP5247429B2 (ja) 2013-07-24
AU2006242842A1 (en) 2006-11-09
ES2400511T3 (es) 2013-04-10
NZ563936A (en) 2010-03-26
US7968513B2 (en) 2011-06-28
EA016039B1 (ru) 2012-01-30
CA2607155C (en) 2016-09-13
IN2014DN10391A (https=) 2015-08-14
JP2008540399A (ja) 2008-11-20
CL2011000039A1 (es) 2011-06-10
UY29515A1 (es) 2007-11-30
EA200702401A1 (ru) 2008-08-29
PL1890720T3 (pl) 2013-06-28
MX2007013866A (es) 2008-04-07
US20090069218A1 (en) 2009-03-12
AU2006242842B2 (en) 2011-12-08
CA2607155A1 (en) 2006-11-09
WO2006117784A2 (en) 2006-11-09
KR20080012933A (ko) 2008-02-12

Similar Documents

Publication Publication Date Title
AR059462A1 (es) Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos
US9961886B2 (en) Antimicrobial compounds and compositions, and uses thereof
US10301339B2 (en) Biofilm inhibiting compositions enhancing weight gain in livestock
DOP2019000250A (es) Composicion farmaceutica que comprende selexipag
US11311511B2 (en) Biofilm inhibiting compositions enhancing weight gain in livestock
PE20130589A1 (es) Composiciones y metodos para suministro al sistema nervioso central de arilsulfatasa a
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
BR112015006828A2 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; método para tratar uma doença em um paciente em necessidade do tratamento; e método para modular a atividade de uma proteína ire1
PH12020500342A1 (en) New disinfectant for hatcheries
ES2888999T3 (es) Uso de una composición bacteriana para tratar infecciones del pie en los ungulados
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
RU2009100745A (ru) Способ лечения слюннокаменной болезни
US7476379B1 (en) Emu-based formulations for the treatment of damaged skin by inhibiting microbial and fungal activity
Murray Touch: Reflections on Human‐Animal Health and Hierarchy
RU2008124738A (ru) Кормовая добавка
Smith et al. Development and Evaluation of Teat Coverage Persistency for New Prototype Dry Period Persistent Barrier Teat Dips
ES2246691B1 (es) Composicion de acido l(+)-lactico de origen natural y organico.
Vostretsov et al. EXPERIENCE OF USE OF HYGIENIC PRODUCTS BASED ON CHLORHEXIDINE DIGLUCONATE FOR PREVENTION OF TEATS DISEASES OF LACTATING COWS
UA122659U (uk) Спосіб комплексного лікування дерматофітозів собак
RU2015112538A (ru) Способ лечения мастита у коров
Mozo et al. Clinical finding in Rasa Aragonesa rams.
EP3735128A1 (en) Biofilm inhibiting compositions enhancing weight gain in livestock
TH118888A (th) วัคซีนต่อต้านเห็บโค

Legal Events

Date Code Title Description
FC Refusal